Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas
暂无分享,去创建一个
Stefan Förster | Bernhard Meyer | Thomas Pyka | Florian Ringel | Jürgen Schlegel | Hans-Jürgen Wester | Jens Gempt | B. Meyer | J. Schlegel | S. Bette | J. Gempt | F. Ringel | T. Pyka | Daniela Hiob | H. Wester | S. Förster | Daniela Hiob | Stefanie Bette | Stefanie Bette
[1] R. Sevick,et al. How often are nonenhancing supratentorial gliomas malignant? A population study , 2002, Neurology.
[2] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[3] Maximilian Niyazi,et al. Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma , 2015, The Journal of Nuclear Medicine.
[4] Irène Buvat,et al. Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis , 2014, The Journal of Nuclear Medicine.
[5] Jochen Herms,et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Chun-Ta Liao,et al. Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma , 2013, The Journal of Nuclear Medicine.
[7] S. Nekolla,et al. Prediction of Glioma Recurrence Using Dynamic 18F-Fluoroethyltyrosine PET , 2014, American Journal of Neuroradiology.
[8] John O. Prior,et al. Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis , 2012, The Journal of Nuclear Medicine.
[9] J. Tonn,et al. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[10] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[11] W. Wick,et al. Neuroradiological Response Criteria for High-grade Gliomas , 2011, Clinical Neuroradiology.
[12] F. Ducray,et al. Chemotherapy in low-grade gliomas , 2012, Current opinion in oncology.
[13] Robert King,et al. Textural features corresponding to textural properties , 1989, IEEE Trans. Syst. Man Cybern..
[14] M. Hatt,et al. Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.
[15] Ronald Boellaard,et al. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[16] W. Wick,et al. Molecular predictors of outcome in low-grade glioma. , 2012, Current opinion in neurology.
[17] William D. Dunn,et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. , 2013, Radiology.
[18] Vicky Goh,et al. Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy? , 2013, The Journal of Nuclear Medicine.
[19] K. Hamacher,et al. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[20] W. Koch,et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] S. Al-Sarraj,et al. Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity. , 2012, Cancer research.
[22] R. Komotar,et al. Predictors of Long-Term Survival in Patients With Glioblastoma Multiforme: Advancements From the Last Quarter Century , 2013, Cancer investigation.
[23] Carsten Denkert,et al. Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization , 2012, PloS one.
[24] S. Lange,et al. Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.
[25] Florent Tixier,et al. Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non–Small Cell Lung Cancer , 2014, The Journal of Nuclear Medicine.
[26] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[27] V. Goh,et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. , 2013, Radiology.
[28] F. Brooks,et al. The Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of Tracer Uptake , 2014, The Journal of Nuclear Medicine.
[29] T. Cloughesy. The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma. , 2011, Seminars in oncology.
[30] M. Hatt,et al. Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.